<DOC>
	<DOCNO>NCT01938105</DOCNO>
	<brief_summary>The purpose study determine feasibility efficacy preoperative nimotuzumab injection combine concurrent chemoradiotherapy initially inoperable , locally advanced cervical cancer .</brief_summary>
	<brief_title>Preoperative Chemoradiotherapy Combined With Nimotuzumab Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Histologically cytologically proven squamous cell cervical cancer Stages IB2IIIB accord FIGO Staging System Age:1875 ECOGï¼œ2 Normal bone marrow function Initial assess consider candidate operation Signed studyspecific consent form Pregnant lactate woman Patients malignancy Patients receive radiotherapy chemotherapy previously Presence uncontrolled lifethreatening illness Allergy platinum monoclonal antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Cervical cancer</keyword>
	<keyword>Nimotuzumab</keyword>
	<keyword>Intensity-modulated radiation therapy</keyword>
	<keyword>Concurrent chemoradiotherapy</keyword>
</DOC>